Diabetes Technology: Markers, Monitoring, Assessment, and Control of Blood Glucose Fluctuations in Diabetes
Open Access
- 1 January 2012
- journal article
- review article
- Published by Wiley in Scientifica
- Vol. 2012, 1-14
Abstract
People with diabetes face a life-long optimization problem: to maintain strict glycemic control without increasing their risk for hypoglycemia. Since the discovery of insulin in 1921, the external regulation of diabetes by engineering means has became a hallmark of this optimization. Diabetes technology has progressed remarkably over the past 50 years—a progress that includes the development of markers for diabetes control, sophisticated monitoring techniques, mathematical models, assessment procedures, and control algorithms. Continuous glucose monitoring (CGM) was introduced in 1999 and has evolved from means for retroactive review of blood glucose profiles to versatile reliable devices, which monitor the course of glucose fluctuations in real time and provide interactive feedback to the patient. Technology integrating CGM with insulin pumps is now available, opening the field for automated closed-loop control, known as the artificial pancreas. Following a number of in-clinic trials, the quest for a wearable ambulatory artificial pancreas is under way, with a first prototype tested in outpatient setting during the past year. This paper discusses key milestones of diabetes technology development, focusing on the progress in the past 10 years and on the artificial pancreas—still not a cure, but arguably the most promising treatment of diabetes to date.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (RO1 DK 51562, RO1 DK 085623)
- National Institute of Diabetes and Digestive and Kidney Diseases (RO1 DK 51562, RO1 DK 085623)
This publication has 168 references indexed in Scilit:
- Artificial Pancreas: Past, Present, FutureDiabetes, 2011
- MD-Logic Artificial Pancreas SystemDiabetes Care, 2010
- Closed-Loop Insulin Delivery Using a Subcutaneous Glucose Sensor and Intraperitoneal Insulin DeliveryDiabetes Care, 2009
- Estimation of Future Glucose Concentrations with Subject-Specific Recursive Linear ModelsDiabetes Technology & Therapeutics, 2009
- Preventing Hypoglycemia Using Predictive Alarm Algorithms and Insulin Pump SuspensionDiabetes Technology & Therapeutics, 2009
- Prediction of Severe HypoglycemiaDiabetes Care, 2007
- French multicentre experience of implantable insulin pumpsThe Lancet, 1994
- A Preliminary Trial of the Programmable Implantable Medication System for Insulin DeliveryNew England Journal of Medicine, 1989
- Defective Glucose Counterregulation after Strict Glycemic Control of Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1987
- Reduction to Normal of Plasma Glucose in Juvenile Diabetes by Subcutaneous Administration of Insulin with a Portable Infusion PumpNew England Journal of Medicine, 1979